Entac Medical

Executive Summary

Entac Medical is a San Francisco-based digital health company that develops wearable devices leveraging predictive analytics and artificial intelligence to interpret biological acoustic signals. Founded in 2018, the company aims to predict downstream adverse events, improve patient compliance through continuous monitoring, and prevent hospital readmissions, particularly for chronic condition management. By operating at the intersection of medical devices and digital health, Entac Medical seeks to enable proactive risk mitigation in clinical settings. The company's technology analyzes acoustic biomarkers (e.g., from heart, lungs, or gut) to identify early warning signs of deterioration, potentially reducing emergency visits and healthcare costs. As a private company with no disclosed funding or commercial products, Entac Medical is in the early stages of development, pending regulatory and clinical validation.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for initial wearable device40% success
• Q2 2026Publication of clinical validation study results50% success
• Q1 2027Strategic partnership with major hospital system for pilot program30% success